Rare diseases
Investigational molecules
Locations
Back to France1 clinical trial in Ris Orangis, France. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FranceThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on metastatic breast cancer treatment, specifically targeting hormone receptor-positive and HER2-negative variants. The research explores innovative combination therapies to enhance treatment outcomes.
Studies evaluate the effectiveness of combining endocrine therapy with specialized medications, while monitoring patient response through advanced diagnostic techniques.
Groundbreaking research in personalized cancer treatment through molecular analysis, focusing on detecting specific mutations that influence treatment decisions and patient outcomes.
This research aims to optimize treatment protocols by monitoring specific genetic markers and adjusting therapies accordingly.
Comprehensive evaluation of combination therapy safety, with particular attention to hematological responses and potential side effects in cancer treatment protocols.
The research focuses on establishing optimal safety profiles for combined therapeutic approaches in advanced breast cancer treatment.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
